
    
      Forty subjects will be assigned to the exercise intervention group, thirty to the metformin
      therapy group and thirty to the control group. Group I will be treated daily with metformin.
      Group II will perform exercise (endurance) three times/week with a personal coach and group
      III will serve as control. All participants will be examined at baseline, after 3 months of
      intervention, after 6 months of intervention and after one year of intervention. Examination
      includes anthropometric measures, measures of ambulatory 24-h blood pressure and insulin
      sensitivity, measures for function and structure of the heart and vessels, analysis of
      atherogenic factors in the blood, aerobic fitness testing and measurement of daily physical
      activity.
    
  